Peroxisomes have long been established to play a central role in regulating various metabolic activities in mammalian cells. These organelles act in concert with mitochondria to control the metabolism of lipids and reactive oxygen species. However, while mitochondria have emerged as an important site of antiviral signal transduction, a role for peroxisomes in immune defense is unknown. Here, we report that the RIG-I-like receptor (RLR) adaptor protein MAVS is located on peroxisomes and mitochondria. We find that peroxisomal and mitochondrial MAVS act sequentially to create an antiviral cellular state. Upon viral infection, peroxisomal MAVS induces the rapid interferon-independent expression of defense factors that provide short-term protection, whereas mitochondrial MAVS activates an interferon-dependent signaling pathway with delayed kinetics, which amplifies and stabilizes the antiviral response. The interferon regulatory factor IRF1 plays a crucial role in regulating MAVS-dependent signaling from peroxisomes. These results establish that peroxisomes are an important site of antiviral signal transduction.
INTRODUCTION
A fundamental feature of eukaryotic cells is the use of membrane-bound organelles to compartmentalize activities and serve as scaffolds for signal transduction. The best-characterized signaling pathways involve membrane-bound receptors that respond to extracellular or lumenal stimuli. In these instances, the spatial separation of an extracellular stimulus from the cytosol mandates the use of organelles as signaling platforms, as transmembrane receptors must transmit information across a lipid bilayer. However, an important gap exists in our knowledge of how stimuli from the cytosol are able to initiate specific signaling events.
How common is the use of organelles in signal transduction from cytosolic receptors? An example of this situation can be found in the study of virus-host interactions. The ability to detect cytosolic viruses depends on the RIG-I-like receptor (RLR) family of proteins, which are soluble RNA helicases that detect viruses containing RNA (and in some cases DNA) genomes (Ablasser et al., 2009; Chiu et al., 2009; Yoneyama et al., 2004) . The best characterized RLRs, RIG-I and MDA-5, detect 5 0 -triphosphatecontaining short double-stranded RNA (dsRNA) and long dsRNA, respectively (Kato et al., 2008; Pichlmair et al., 2006) . RLRs can either detect viral RNA directly or after RNA polymerase III-mediated transcription of microbial DNA (Ablasser et al., 2009; Chiu et al., 2009; Kato et al., 2008) . Mice deficient in either of these RLRs are sensitive to different classes of viruses, underscoring both their specificity of action and their importance in immune defense (Gitlin et al., 2006; Kato et al., 2006) .
Although RIG-I and MDA-5 have specificities for different ligands, both induce a common signaling pathway that triggers the expression of type I interferons (IFNs) and IFN-stimulated genes (ISGs). Many ISGs function as direct antiviral effectors, acting to prevent viral genome replication, viral particle assembly, or virion release from infected cells. Generally, it is thought that RLRs induce the expression of IFNs that act in both autocrine and paracrine manners to amplify ISG expression. However, ISGs can also be induced directly upon viral infection, without the need for IFN signaling (Collins et al., 2004; Mossman et al., 2001) . At the receptor-proximal level, RLR-dependent responses are regulated by the adaptor protein MAVS (also called IPS-1, Cardif, or VISA) (Nakhaei et al., 2009) . Upon viral detection, MAVS binds to RLRs and promotes the activation of NF-kB, AP-1, and various interferon regulatory factors (IRFs), which act to induce ISGs and create an antiviral state in the cell. Although much has been learned about the genetics of RLR signaling, less is known about where within the cell signal transduction occurs. Identifying the sites of RLR signal transduction is critical to understanding how antiviral networks are integrated into the general cellular infrastructure within which they operate.
The first clue that cytosolic RLR signaling may occur from organelles came from studies of the MAVS adaptor. MAVS contains a C-terminal transmembrane domain that anchors it to the mitochondrial outer membrane (Seth et al., 2005) . It is from this location that MAVS is thought to engage active RLRs and induce signal transduction. Whether mitochondria are the only organelles that promote RLR-mediated signaling has not been addressed.
Mitochondria have long been appreciated to have an intimate functional relationship with peroxisomes (Hettema and Motley, 2009 ). Both are membrane-bound organelles found in mammalian cells and are involved in the metabolism of lipids and reactive oxygen species. However, while mitochondria are well-established sites of both antiviral signaling and antiviral apoptosis, peroxisomes are thought to function solely as metabolic organelles.
Recently, several mitochondrial proteins have been found to reside also on peroxisomes. Included in this group are the outer membrane proteins Fis1 and Mff, which regulate the morphology of both organelles (Gandre-Babbe and van der Bliek, 2008; Koch et al., 2005) . Interestingly, Fis1, Mff, and MAVS all have similar domain structures: each contains an N-terminal effector domain and a C-terminal localization motif, which consists of a transmembrane domain and a short lumenal tail containing basic amino acids. That other so-called ''tail-anchored'' mitochondrial outer membrane proteins operate from peroxisomes raised the possibility that MAVS also functions from these organelles.
We have discovered that MAVS does indeed reside on peroxisomes and can induce antiviral signaling from this organelle. Our work supports a model whereby peroxisomal MAVS induces the immediate expression of antiviral factors that function to contain a nascent infection. Long-term containment of the infection, however, requires the function of mitochondrial MAVS as well. These data demonstrate that peroxisomes are not simply metabolic organelles, but rather serve as critical subcellular hubs that promote MAVS-dependent antiviral immunity.
RESULTS

MAVS Is Located on Both Mitochondria and Peroxisomes
MAVS has a similar domain organization to other tail-anchored membrane proteins that function from mitochondria and peroxisomes (Gandre-Babbe and van der Bliek, 2008; Koch et al., 2005) . We therefore sought to determine whether MAVS also resides on peroxisomes. The subcellular localization of MAVS was examined in mouse embryonic fibroblasts (MEFs) whose peroxisomes were marked by a DsRed allele containing a type 1 peroxisomal targeting signal (PTS1). In addition to staining structures that appeared to be mitochondria, MAVS was detected on PTS1-positive peroxisomes scattered throughout the cell ( Figure 1A) . A similar staining pattern was seen for Mff ( Figure 1A ), which functions from both peroxisomes and mitochondria (Gandre-Babbe and van der Bliek, 2008) . In contrast, the Toll-like receptor (TLR) adaptor protein TIRAP (Fitzgerald et al., 2001; Horng et al., 2001) was not detected on peroxisomes ( Figure 1A ). To confirm that the peroxisomal staining was distinct from mitochondria, we also stained cells with MitoTracker. Although no costaining was detected between PTS1 and MitoTracker, MAVS was detected on both PTS1-positive peroxisomes and MitoTracker-positive mitochondria ( Figure 1B) . Similar results were obtained when epitope-tagged MAVS in murine macrophages ( Figure S1 available online) or endogenous MAVS in human hepatocytes were examined ( Figure 1C ). As an independent means of assessing MAVS localization, hepatocytes were biochemically fractionated to separate peroxisomes and mitochondria, which were respectively distinguished by Pex14 and mtHSP70 ( Figure 1D ). Both MAVS and Fis1 (a protein that occupies both organelles [Koch et al., 2005] ) were detected in fractions containing either peroxisomes or mitochondria. Collectively, on the basis of studies in both human and mouse cells, these data establish that peroxisomes are a bona fide reservoir of the RLR adaptor protein MAVS.
One possible reason MAVS is present on peroxisomes is that newly synthesized MAVS might first pass through peroxisomes en route to mitochondria. To address this possibility, we used human fibroblasts from a patient lacking a functional Pex19 protein. Pex19 controls peroxisome biogenesis, and thus Pex19-deficient cells contain no peroxisomes or peroxisomal remnant structures (Matsuzono et al., 1999; Sacksteder et al., 2000) . Notably, MAVS was delivered to mitochondria in Pex19-deficient cells ( Figure 1E ), indicating that the pathway to mitochondria does not require a peroxisomal intermediate. Moreover, MAVS localized to both peroxisomes and mitochondria in Pex19-deficient cells that expressed Pex19 after transient transfection or retroviral gene transfer ( Figure 1E ). It is therefore unlikely that localization of MAVS to peroxisomes is the result of a biosynthetic pathway for delivering outer membrane proteins to mitochondria.
A Systematic Strategy to Separate Functions of Peroxisomal and Mitochondrial MAVS Our finding that MAVS is located on peroxisomes raised the possibility that these organelles serve as a site of antiviral signal transduction. We first considered using Pex19-deficient cells to address sufficiency of mitochondrial MAVS in antiviral signaling, but since peroxisomes are required for biochemical processes that occur in mitochondria, Pex19-deficient cells have profound defects in mitochondrial function (Wanders, 2004) . We therefore used the alternative approach of genetically separating the putative mitochondrial and peroxisomal functions of MAVS. This was accomplished by replacing the previously defined MAVS localization motif (Seth et al., 2005) with a set of domains that instead direct the protein to a single compartment (Figure 2A ). Using the localization motif of the peroxin Pex13 (Fransen et al., 2001 ), we created a protein called MAVS-Pex. By deleting the MAVS localization motif, we also created a cytosolic allele (MAVS-Cyto) (Seth et al., 2005) . Because the fidelity of mitochondrial sorting signals is not always transferrable to other proteins (Ingelmo-Torres et al., 2009), we lastly created two different alleles of MAVS containing a sorting signal derived from two proteins residing on the mitochondrial outer membrane protein, either OMP25 or Fis1 (Koch et al., 2005; Nemoto and De Camilli, 1999) .
Using retroviral gene transfer of MAVS-KO MEFs, we created cell lines expressing comparable levels of each MAVS allele ( Figures 2B and 2C ) and determined their localizations by confocal microscopy. Full-length MAVS (MAVS-WT) was located on both mitochondria and peroxisomes (data not shown), and MAVS-Cyto was found on neither organelle ( Figure 2D and (E) Pex19-deficient human fibroblasts were stained for endogenous MAVS before and after introduction of a functional Pex19 allele as indicated. Mitochondria were stained with anti-mtHSP70 antibody. Peroxisomes were visualized by transfection with a bicistronic construct encoding EGFP-PTS1 and Pex19. See also Figure S1 . Figure S2 ). As expected, MAVS-Pex was found exclusively on peroxisomes ( Figure 2D and Figure S2 ). Of the alleles containing the putative mitochondrial targeting sequences, the allele harboring the Fis1 transmembrane domain was found primarily on mitochondria, whereas the one containing the OMP25 transmembrane domain was located on both mitochondria and peroxisomes ( Figure 2D and Figure S2 ). We therefore refer to the mitochondria-specific allele as MAVS-Mito to indicate its exclusive localization to mitochondria and the allele found on both organelles as MAVS-Mimic to indicate its ability to copy the localization pattern of MAVS-WT. Collectively, this set of MAVS-expressing MEF lines differs only in the subcellular positioning of the signaling domain of MAVS and thereby provides an ideal system to determine the relative roles of mitochondrial and peroxisomal localization in MAVS-dependent signal transduction.
MAVS-Dependent Signaling Occurs from Both Peroxisomes and Mitochondria
To address the function of peroxisomal MAVS, we monitored the expression of antiviral factors in response to infection with reovirus. We chose reovirus because it is a known inducer of both RIG-I and MDA-5 signaling pathways (Loo et al., 2008) , allowing direct examination of both RLRs in a single experiment.
Cells were infected with reovirus, and extracts were examined at various times for expression of viperin, a well-characterized ISG (Chin and Cresswell, 2001; Severa et al., 2006) . MAVS-WT-, -Mimic-, or -Mito-expressing cells induced viperin expression in response to infection ( Figure 3A ). This response was MAVS dependent, as MAVS-KO cells showed no change in viperin expression. MAVS-Cyto cells were unable to induce viperin expression, confirming that membrane localization is necessary for MAVS function (Seth et al., 2005) . Interestingly, despite the fact that MAVS-Pex is found only on peroxisomes, MAVSPex cells induced viperin expression after infection ( Figure 3A ).
An examination of the kinetics of ISG induction indicated that cells containing MAVS on peroxisomes (MAVS-WT, -Mimic, and -Pex) induced viperin expression within 4 hr of infection. In contrast, exclusive localization to mitochondria (MAVS-Mito) resulted in viperin expression with delayed kinetics ( Figure 3A ). These results suggest that localization of MAVS to either peroxisomes or mitochondria is sufficient to induce antiviral signaling but that peroxisomal residence allows for more rapid expression of ISGs. Interestingly, rapid expression of ISGs by MAVS-Pex appeared to be transient, as viperin expression decreased at later times of infection ( Figure 3A ).
To determine whether peroxisomal signaling by MAVS requires signaling by both RIG-I and MDA-5, we performed similar experiments using influenza virus, which activates the RIG-I pathway exclusively (Gitlin et al., 2006; Kato et al., 2006) . A similar pattern of viperin expression was observed with influenza as with reovirus, although the kinetic differences between MAVS-Pex and -Mito were even more pronounced with influenza ( Figure 3B ). Thus, RIG-I signaling alone is sufficient to induce MAVS-dependent signaling from peroxisomes. In sum, these data indicate that peroxisomal MAVS induces rapid but transient viperin expression, whereas mitochondrial MAVS induces delayed but stable viperin expression. Signaling from both organelles thus contributes to the rapid and stable expression of viperin that is observed in MAVS-WT cells.
While the above studies provide strong genetic evidence for MAVS signaling from peroxisomes in a population of cells, they do not allow us to examine individual cells for compartment-specific signaling events. To address this, we took advantage of the fact that various signaling pathways induce morphological changes in the organelles where signaling occurs, including RLR-dependent activities on mitochondria (Castanier et al., 2010; Yasukawa et al., 2009) . We reasoned that if signaling was actually occurring on these organelles, then their morphology may change during viral infection. In support of this S3B ). Cells expressing MAVS-Mito or MAVS-Cyto exhibited little or no change in peroxisome morphology. These data suggest that RLRs engage peroxisomal MAVS to induce peroxisomal tubules and that the extent of tubulation is determined by the concentration of MAVS on these organelles. These independent assays demonstrate that MAVS-dependent signaling occurs locally (on the peroxisome).
Peroxisomal MAVS Triggers an IFN-Independent Signaling Pathway that Promotes ISG Expression
The different kinetics of viperin induction by peroxisomal and mitochondrial MAVS suggest that more than one mechanism of RLR-induced ISG expression may operate in virus-infected cells. ISG expression can be induced directly, or it can be induced indirectly through the action of secreted type I IFNs (Collins et al., 2004; Mossman et al., 2001) . To determine whether IFNs contribute to expression of ISGs induced by mitochondrial or peroxisomal MAVS, we monitored the rate of IFN production by reovirus-infected cells. As expected, IFN production was dependent on membrane-localized MAVS, and all mitochondrial MAVS proteins (MAVS-WT, -Mimic, and -Mito) triggered IFN production, though with delayed kinetics in the case of MAVS-Mito ( Figure 3C ). These data indicate that in the case of the mitochondria-localized MAVS proteins, IFN expression coincides with ISG induction. Surprisingly, no detectable IFNs were produced by MAVS-Pex cells. Similar results were obtained with cells infected with influenza virus (Figure 3D ), though the relative amounts of IFNs produced with these two viruses differed dramatically, reflecting unique aspects of each virus life cycle. However, our inability to detect a role for IFNs in promoting viperin expression in MAVS-Pex cells was not due to an inability of the cells to respond to IFNs, because addition of recombinant IFNb was sufficient to induce viperin expression in all cells examined ( Figure 3E ).
The observation that viperin can be expressed in the absence of type I IFN induction suggests that IFNs may not contribute to ISG expression induced by peroxisomal MAVS. We tested this possibility by infecting cells under conditions in which the functions of IFNs are prevented, by either disrupting protein secretion with brefeldin A (BFA) or by utilizing neutralizing antibodies against secreted IFNs. Both treatments disrupted the activity of type I IFNs produced during reovirus infection (Figures 4A and 4B) and inhibited the expression of viperin by cells expressing mitochondrial MAVS (MAVS-WT, -Mimic, and -Mito) ( Figures  4C and 4D ). These data indicate that signaling by IFNs promotes viperin expression. However, because these treatments did not completely abolish viperin expression, an IFN-independent pathway of viperin induction must also exist. Interestingly, MAVS signaling from peroxisomes primarily utilized the IFN-independent pathway, as viperin expression within MAVS-Pex cells was largely resistant to these treatments ( Figures 4C and 4D ). These data therefore indicate that the subcellular positioning of MAVS determines the type of signaling pathway activated during viral infection. Peroxisomal MAVS induces the rapid and direct expression of viperin, which is followed by mitochondrial MAVS triggering viperin expression directly, as well as indirectly through the IFN-mediated feed-forward loop.
The Global Transcriptional Response to Reovirus Infection Is Mediated by the Collective Actions of MAVS-Dependent Peroxisomal and Mitochondrial Signaling
Based on the set of candidate genes examined, our data suggests that peroxisomal and mitochondrial MAVS each induce a complementary set of genes that are collectively induced by MAVS-WT. To determine whether this is the case, microarrays were performed on reovirus-infected cells. Infections were performed for 3, 9, or 16 hr, and RNA was collected for genomewide expression analysis. At all times examined, similar expression profiles were observed when MAVS-WT and MAVS-Mimic cells were compared, confirming that similarities in MAVS localization are predictive of similarities in MAVS function (Figures 5A and 5B). These cells induced the expression of numerous ISGs, IFNs, and chemokines ( Figure 5C ). Notably, we were unable to detect the expression of the proinflammatory cytokines TNFa, IL-1b, or IL-6 (data not shown). MAVS-Cyto cells were most 
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.05 1 similar to MAVS-KO cells ( Figures 5A and 5B) , further confirming that membrane localization of MAVS is critical for its function in antiviral signaling. Interestingly, MAVS-Pex-or -Mito-expressing cells displayed a transcriptome that each partially overlapped with that of MAVS-WT cells, but were distinct from one another ( Figures 5B and 5C ). For example, at 16 hr after infection, MAVS-Mito cells upregulated genes encoding chemokines, ISGs, IFNb, and several IFNa family members (Figures 5B and  5C ). MAVS-Pex cells also induced the expression of chemokines and ISGs, but without any detectable changes in IFN expression and with much faster kinetics (within 3 hr). Thus, on a global scale, peroxisomal MAVS induces the rapid expression of ISGs without inducing IFN expression, whereas mitochondrial MAVS promotes IFN and ISG expression but with delayed kinetics. We confirmed these results by examining the expression of several candidate IFNs and ISGs using nCounter, which allows for multiplex analysis of gene expression with the sensitivity of quantitative RT-PCR (Geiss et al., 2008) (Figures S4A and  S4B) . Overall, at all times examined, most genes expressed by either peroxisomal or mitochondrial MAVS were induced by MAVS-WT or -Mimic ( Figures 5B and 5C ). These data therefore support a model whereby the host transcriptional response is the result of MAVS signaling from both mitochondria and peroxisomes. We do note however, that the magnitude of antiviral gene expression induced by cells expressing MAVS-WT or MAVS-Mimic was greater than the magnitude induced by cells where MAVS was restricted to a single organelle, which suggests that signaling from both organelles may be coordinated to ensure maximal antiviral gene expression.
Peroxisomal Signal Transduction Creates a Transient but Functional Antiviral State MAVS-dependent signaling promotes an antiviral state, which is functionally defined as the ability of cells to restrict multiplication of viruses. To determine the significance of mitochondrial or peroxisomal signaling pathways in this regard, we asked whether signaling from either organelle is sufficient to restrict viral replication. We addressed this by infecting MAVS-expressing cells with reovirus and measuring production of infectious virions over time. As expected, MAVS-WT and -Mimic cells were most resistant to infection, and MAVS-KO and -Cyto cells were most susceptible ( Figure 6A ). These data indicate that MAVS signaling is required to limit reovirus replication. Interestingly, cells expressing MAVS-Pex or MAVS-Mito exhibited an unusual biphasic behavior. Over the first 24 hr, these cells restricted viral replication as well as MAVS-WT, but this capacity diminished, and by 72 hr were most similar to the MAVS-KO cells. These data establish that signaling from either peroxisomes or mitochondria is sufficient to induce a functional antiviral response, but signaling from both organelles is necessary for maximal containment of reovirus replication.
Vesicular stomatitis virus (VSV) is one of many viruses that interfere with type I IFN expression as part of their pathogenic lifecycle ( Figures 6B and 6C ) (Ferran and Lucas-Lenard, 1997) . Under these conditions, the IFN-independent means of signaling that is induced by peroxisomal MAVS may be particularly important in controlling infection. Consistent with this idea, MAVS-Mito cells were as susceptible to VSV infection as MAVS-KO or -Cyto cells ( Figure 6D ), suggesting that in the absence of IFN production, the mitochondrial signaling pathway is functionally defective. Most notably, MAVS-Pex cells were nearly as effective at controlling VSV as MAVS-WT cells ( Figure 6D ). These results suggest that MAVS signaling from peroxisomes is the primary means of controlling viruses that interfere with IFN expression, thus underscoring the importance of this organelle in host defense.
Downstream Regulators of MAVS Signaling from Peroxisomes
To identify downstream signaling regulators of peroxisomal MAVS, we overexpressed each MAVS allele in 293T human kidney epithelial cells. MAVS-WT, -Mimic, -Mito, and -Pex each induced the activation of reporter genes controlled by NF-kB and AP-1 ( Figure 6E ). In addition, an IRF1 reporter and an ISRE that typically reports IRF3 activity were induced, suggesting a role of these IRFs in MAVS signaling from peroxisomes ( Figure 6E ). MAVS-Cyto did not activate any reporter. Within these cells, we found that ISRE activation by either MAVS-WT or MAVS-Pex was potentiated by overexpression of TRAF3 and inhibited by expression of a dominant negative allele of TRAF6 ( Figure S5A ), suggesting the involvement of these known RLR regulators in peroxisomal signaling (Saha et al., 2006; Yoshida et al., 2008) . In contrast, expression of a dominant-negative allele of the antiviral factor FADD has a minimal affect on MAVS signaling ( Figure S5A ), which is consistent with a recent report (Balachandran et al., 2007) . Notably, overexpression of NLRX1, a negative regulator that is uniquely located on mitochondria ( Figure S5B ) (Moore et al., 2008) did not interfere with MAVS-Pex signaling, but did inhibit signaling by MAVS-WT ( Figure S5A) .
To confirm the roles of IRF1 and IRF3 in peroxisomal signaling, we enlisted VSV to study the IFN-independent means of ISG expression, since only the peroxisomal pathway functions to control replication of this virus, although some ISGs were Figures S2 and S5C) . In response to reovirus infection, macrophages that contained mitochondrial MAVS (MAVS-WT or -Mito) induced transcripts encoding IFNs ( Figure 7C ) and ISGs ( Figure S5D ). MAVS-Cyto was unable to induce gene expression in response to reovirus infection. Unlike MEFs, reovirus-infected macrophages expressed inflammatory cytokines such as IL-1b ( Figure 7D ), IL-6, IL-12b, and TNFa ( Figure S5D and data not shown). Another difference between MEFs and macrophages was that MAVS-Mito-expressing macrophages exhibited no kinetic delay in reovirus-induced gene expression. These results suggest that like the TLR adaptor MyD88, the function of MAVS is controlled in a cell type-specific way.
Peroxisomal MAVS induced the expression of some genes to the same levels observed with the WT allele, such as A20, IL-1b, Cox2, CXCL2 (MIP-2a), CCL4 (MIP-1b), and Fos ( Figure 7D ), whereas others were induced more than 3-fold but still less than in WT cells, e.g., viperin, IFIT1, and IFIT2 ( Figure S5D ). Of note, peroxisomal MAVS was unable to induce the expression of any IFN gene in macrophages ( Figure 7C) . Thus, despite cell typespecific activities of MAVS, a fundamental feature of the RLR signaling network appears to be that peroxisomal MAVS functions to promote an IFN-independent means of gene expression.
DISCUSSION
The best-characterized sensors of cytosolic viruses are members of the RLR family, which enlist the adaptor protein MAVS to initiate antiviral signaling (Kawai and Akira, 2007) . MAVS is one of a growing group of tail-anchored membrane proteins, which contain a C-terminal transmembrane domain (GandreBabbe and van der Bliek, 2008; Koch et al., 2005; Seth et al., 2005) . This anchor was originally reported to promote MAVS recruitment to the mitochondrial outer membrane, providing a landmark of where RLR signaling can occur (Seth et al., 2005) . This discovery established that cytosolic detection systems, like extracellular detection systems (e.g., TLRs), use membranes as scaffolds for signal transduction. In the TLR network, however, signaling occurs from a variety of different organelles, not just one (Barton and Kagan, 2009 ). We report here that in addition to mitochondria, the antiviral signaling protein MAVS is located on peroxisomes in several human and murine cell types.
The central finding of this study-that peroxisomes are a site of signal transduction-was established with a complementary set of assays that measured (1) messenger RNAs (mRNAs) encoding ISGs and IFNs, (2) protein levels of ISGs and IFNs, (3) the induction of a functional antiviral state in cells, and (4) infectioninduced changes in peroxisome morphology. In each of these assays, we found that peroxisomes are a site of MAVS-dependent signaling. Moreover, we obtained these results by using several unrelated RNA viruses as physiological triggers of RLR signaling, which suggests that peroxisomal signaling is a fundamental component of the RLR network.
The RLR signaling network now joins the TLRs as pattern recognition systems that signal from multiple organelles. Both systems require that a transmembrane protein be positioned on specific organelles-the receptors themselves in the case of TLRs and the MAVS adaptor in the case of RLRs (Akira et al., 2006; Barton and Kagan, 2009) . Interestingly, when considering these two networks, the function of diversifying signaling locale appears to be distinct. In the case of TLRs, differential receptor placement diversifies the types of pathogens that can be detected: TLRs found on endosomes recognize viruses, while TLRs found on the plasma membrane typically recognize bacteria. In contrast, differential MAVS placement does not diversify the types of viruses detected by RLRs, but diversifies the types of signaling pathways that are activated. In the case of reovirus and influenza virus infection of fibroblasts, peroxisomal MAVS triggers the rapid expression of ISGs, whereas mitochondrial MAVS triggers delayed ISG and IFN expression. This diversification is functionally important, as our data indicate that MAVS signaling must occur from both organelles to limit reovirus replication.
Our studies revealed another important similarity between the RLR and TLR networks, that of cell type-specific functions for adaptor proteins. In fibroblasts, MAVS functioned to induce expression of IFNs and ISGs, but not inflammatory cytokines. In contrast, IFNs, ISGs, and cytokines were all induced by MAVS signaling in macrophages. Thus, MAVS can be grouped with the TLR adaptor MyD88 as immune regulators that induce cell type-specific transcriptional responses. What is the benefit of cell type-specific actions of innate immune signaling pathways? One benefit may lie in the primary functions of the cells responding to a given virus. For example, macrophages are dedicated sentinels of the innate immune system. As such, within these cells, infection triggers MAVS-dependent inflammatory cytokine production and antiviral factors. Fibroblasts, in contrast, are tissue-resident cells that are primarily involved in organ homeostasis-a condition that is disrupted under inflammatory conditions. Thus, designing MAVS to induce antiviral factors but not inflammatory cytokines in fibroblasts may aid these cells in maintaining homeostasis under infectious conditions. We speculate that the diversification of adaptor functions in innate immunity may be a general mechanism to tailor signaling pathways to the needs of functionally diverse cell types.
Our finding that peroxisomal localization of MAVS is required for rapid but transient induction of antiviral ISGs whereas mitochondrial MAVS promotes ISG expression with delayed kinetics in fibroblasts is especially intriguing. The kinetic differences of ISG expression were explained by the observation that peroxisomal MAVS induced a cell-intrinsic means of ISG induction, which occurred in the absence of detectable IFN expression. Mitochondrial MAVS induced cell-intrinsic ISG expression as well, but maximal induction occurred through the actions of secreted IFNs. Our studies did not reveal an obvious difference in the downstream regulators activated by peroxisomal versus mitochondrial MAVS, but the studies performed in 293T cells suggest that the selective positioning of negative regulators (e.g., NLRX1) may contribute to organelle-specific responses. Future work will be required to address this point.
The functional importance of RLR signaling from peroxisomes was best revealed by experiments with VSV, which interferes with IFN expression and renders the mitochondrial pathway ineffective. As a result, even though MAVS is present on mitochondria and peroxisomes in WT cells, a functional antiviral response against VSV is only induced by the peroxisomal pathway. We also exploited VSV infection to dissect the peroxisomal signaling pathway using cells derived from geneticallydeficient mice. While we found that IRF3 plays a role in ISG expression, this factor is also involved in the regulation of IFN expression (Sato et al., 2000) and may therefore be considered a more general regulator of antiviral gene expression. Indeed IRF3 is also involved in IFN expression induced by non-RLRs (Kawai and Akira, 2007) . IRF1, on the other hand, is needed for expression of all ISGs that we examined in VSV-infected cells and is not required for IFN expression (Tamura et al., 2008) . IRF1 may thus uniquely control IFN-independent signaling events that lead to ISG expression and antiviral immunity. Our experiments with VSV also revealed a probable benefit of utilizing both IFN-dependent and IFN-independent mechanisms of ISG induction: for pathogens that disrupt the In fibroblasts, the cooperative actions of MAVS on peroxisomes and mitochondria are needed for maximal antiviral immunity, and signaling from each organelle occurs independently of the other. As such, it appears that a simple mathematical equation can be proposed to explain antiviral signal transduction: RLR = Pex + Mito ( Figure 7E ). If either term in this equation is removed, then the RLR signaling network operates inefficiently, and antiviral immunity is compromised. We note however, that maximal ISG and IFN expression requires signaling from both organelles, which likely indicates that crosstalk exists to allow the two pathways to be properly integrated.
In closing, our studies establish a new function for peroxisomes, that of a subcellular compartment that promotes a rapid response to viral infection. We speculate that additional organelles may harbor pathogen detection systems, and our work provides a mandate to expand the search for these organelles.
EXPERIMENTAL PROCEDURES
Plasmids and Antibodies pCMV2 Flag-IPS-1, pEF-HA-MAVS, pCDNA3-HA-NLRX1, and the myc-Mff plasmid were gifts from S. Akira, Z. Chen, J.Ting, and A. van der Bliek, respectively. The plasmids Dsred-PTS1, bicistronic Pex19 / EGFP-PTS1, Pex19, EGFP-Pex19, Pex13p-EGFP, and pCMV-TIRAP-flag have been described (Fransen et al., 2001; Horng et al., 2001; Vastiau et al., 2006) . Pex19 was amplified from EGFP-Pex19 and inserted into the retroviral vector pMSCV IRES GFP. All MAVS constructs are based on the allele BC044952. The full-length (1-540) and a truncated (1-500) sequence were amplified from pEF-HA-MAVS by PCR. For chimeric MAVS alleles, the C-terminal 40 residues were replaced by the following sequences: PEX13 (NM_002618) residues 136-233, FIS1 (NM_016068) residues 127-152, and Omp25 (NM_022599) residues 109-145 by overlap extension PCR and cloned into pMSCV IRES GFP.
Anti-Pex19 and anti-Pex14, anti-viperin, and anti-myc 9E10 were gifts from M. Fransen, P. Cresswell, and S. Hansen, respectively. Anti-MAVS (Bethyl Laboratories), anti-mtHSP70 (ABR Affinity Reagents), anti-Flag M2 (Sigma), anti-Fis (Santa Cruz), anti-HA (Roche), and anti-b-actin (Sigma) were used according to the manufacturers' recommendations.
Cell Lines, Retroviral Gene Transfer, and Cell Fractionation MEFs, Huh-7, 293T, Vero, and MDCK cells were cultured according to standard techniques. MAVS-KO MEFs, PEX19-deficient human skin fibroblasts, and L929 cells stably expressing an ISRE-luciferase reporter were provided by Z. Chen, R. Wanders, and B. Beutler, respectively. MEFs lacking IRF1, 3, and 5 were provided by K. Fitzgerald. MAVS and PEX19 alleles were introduced in MAVS-KO MEFs and Pex19-deficient human skin fibroblasts by retroviral gene transfer and then sorted for equal GFP fluorescence to normalize MAVS expression levels. Fractionations of HepG2 cells were performed as described (Fransen et al., 2004) .
DNA Transfections and Immunofluorescence
MEFs and Huh-7 cells were transfected with Fugene-6 (Roche) for 24 hr at 37 C. Where indicated, cells were incubated with 250 nM MitoTracker Deep
Red FM (Molecular Probes) for 30 min at 37 C prior to fixation. For NLRX1 visualization, Huh-7 cells expressing HA-NLRX1 were incubated with 160 nM MitoTracker for 20 min at 37 C and permeabilized with 0.1% saponin in 80 mM PIPES, 5 mM EGTA, and 1 mM MgCl 2 (pH 6.8) for 10 min at 25 C. Cells were fixed with 2% paraformaldehyde for 20 min at 25 C and permeabilized for 10 min with 0.1% Triton X-100. Samples were treated with block buffer (2% goat serum and 50 mM ammonium chloride in PBS) for 30 min, and the appropriate antibodies were diluted in block buffer. Antibody binding was detected using antibodies conjugated with Alexa fluor 488, 594, or 647 (Molecular Probes). Samples were imaged on a Nikon TE-2000 inverted microscope fitted with a video-rate confocal system consisting of a spinning disk confocal head (Yokogawa). Using a 1003 oil immersion objective with a numerical aperture of 1.4, confocal images were collected as a 3D stack with a focal step size of 0.27 mm. Micrographs were processed with Adobe Photoshop.
Virus Stocks, Infections, and Plaque Assay Reovirus Type 3 Dearing (Cashdollar lab clone) was propagated on L929 cells and plaque purified as described (Furlong et al., 1988) . Cells were seeded 12-16 hr prior to infection on 6-well plates. On the day of infection, medium was replaced by addition of 2 ml fresh medium containing virions at a multiplicity of infection (MOI) of 100, unless stated otherwise. Where indicated, cells were preincubated with 20 mg/ml brefeldin A (Invitrogen) and infections were carried out in the presence of the drug. Type I IFN activity was blocked by addition of 250 neutralizing units/ml anti-IFNb and 500 neutralizing units/ml antiIFNa (PBL InterferonSource) antibodies at the time of infection. So that reovirus replication could be assessed, purified virions were diluted in 100 ml attachment buffer (phosphate-buffered saline with 2 mM MgCl 2 ) and incubated with cell monolayers for 1 hr at room temperature. After removal of unabsorbed virus by two washes with attachment buffer, cells were incubated for the indicated times. Next, cells were lysed by freeze/thaw and infectious titers were measured by serial dilution onto L929 cells as described (Middleton et al., 2007) . Influenza virus (A/Puerto Rico/8/34, H1N1) lacking the NS1 gene was propagated in Vero cells as described (García-Sastre et al., 1998) and titrated by plaque assay on MDCK cells. For infection, cell monolayers were incubated with DNS1 virus at a MOI of 5 for 1 hr at 37 C in Dulbecco's modified Eagle's medium supplemented with 0.3% bovine serum albumin, washed, and incubated with growth media. VSV (Indiana) infections were performed as described (Cureton et al., 2009) , and viral titer was determined by plaque assay on Vero cells.
Immunoblotting and Type I IFN Bioassay Protein extracts were prepared by standard techniques, and 40 mg cell extract was separated by SDS-PAGE and analyzed by immunoblot. Type I IFN activity was measured as described (Jiang et al., 2005) .
Gene Arrays and Bioinformatics Cells were infected as described above, and RNA was purified with QIAShredder and the RNeasy Mini Kit (QIAGEN). Microarrays were performed by the Molecular Genetics Core Facility at Children's Hospital Boston supported by NIH-P50-NS40828 and NIH-P30-HD18655. Quantile normalization was used for signal extraction and normalization. Two criteria were applied to identify (C and D) Immortalized MAVS-KO macrophages were retrovirally transduced with MAVS-WT, -Pex, -Mito, and-Cyto for 48 hr. The transduction efficiency of each cell population was determined to be 20%-30% as assessed by fluorescence microscopy. Cells were infected with reovirus and at the indicated times and were harvested, and RNA was analyzed for expression of type I IFN (C) and other inflammatory genes (D) with nCounter. See also Figure S5 . (E) Model of organelle specific MAVS signaling in fibroblasts. Peroxisomal MAVS is essential for rapid ISG expression independent of type I IFN, whereas mitochondrial MAVS induces ISGs with delayed kinetics and primarily dependent on type I IFN secretion. Therefore, peroxisomal MAVS mediates immediate and transient antiviral effects, while mitochondrial MAVS promotes a sustained response later during infection. See also Figure S5 . differentially regulated genes: (1) statistical significance of p < 0.05 and (2) fold change of greater than 2 (ratio > 2.0 or < 0.5). Four thousand eighty-nine genes passed both criteria for at least one of the assayed conditions. Samples are clustered based on the Pearson's correlation coefficient for the profile of those 4089 genes. The Pearson correlation, hierarchical clustering, and heat map were generated with the R functions ''cor,'' ''hclust,'' and ''heatmap,'' respectively. Signal intensity that reflected mRNA expression was presented on heat maps or scatterplots on a log scale according to a color-coded intensity scale with R software (The R Project for Statistical Computing). Each data point in the scatterplots presented indicates a gene whose expression level exhibited a change >2-fold.
mRNA Detection and Analysis with nCounter nCounter CodeSets were constructed to detect genes selected by the GeneSelector algorithm and additional controls as described. Two hundred and forty thousand cells were lysed in RLT buffer (QIAGEN) supplemented with b-mercaptoethanol. Five percent of the lysate was hybridized for 16 hr with the CodeSet and loaded onto the nCounter prep station, followed by quantification with the nCounter Digital Analyzer. To allow for side-by-side comparisons of nCounter experiments, we normalized the nCounter data in two steps. We first controlled for small variations in the efficiency of processing by normalizing measurements from all samples analyzed on a given run to the levels of chosen positive controls provided by the nCounter instrument. Second, we normalized the data obtained for each sample to the expression of nine control genes (Gapdh, Ik, Mea1, Ndufs5, Ndufa7, Rbm6, Shfm1, Tomm7, and Ywhaz). These genes were described to be unchanged in cells exposed to a variety of infectious conditions (Amit et al., 2009 ). For every sample, we computed the weighted average of the mRNA counts of the nine control transcripts and normalized the sample's values by multiplying each transcript count by the weighted average of the controls.
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